FDA OKs Providence Medical’s Corus Navigation System with Medtronic’s StealthStation

Providence Medical Technology has earned U.S. Food and Drug Administration (FDA) clearance for use of its Corus navigation access system with its spinal system for spinal surgery. Corus navigation access was designed for use with Medtronic’s StealthStation for posterior spinal fusion surgeries.
 
The Corus navigation access system helps surgeons locate, access, and prepare facet joints for posterior fusion.
 
Providence highlighted that using Corus navigation for spinal fusion may boost precision and accuracy with surgical instruments and CAVUX FF-LX spinal implants. It can also improve visualizing facet joints and other anatomical structures, as well as reduce risk and operating time.
 
Bryan Lee, MD, a neurosurgeon at Barrow Neurological Institute, said, “The newly released CORUS navigation system offers simplicity and accuracy for placement of CAVUX FFS-LX implants and provides the surgeon with a truly minimally invasive approach for posterior fusion, with a wide array of indications, including advanced disc degeneration and adjacent segment disease.”
 
“We are thrilled to integrate our CORUS Spinal System with the leading surgical navigation platform and allow for incredible precision and safety in posterior fusion surgeries,” added Jeff Smith, CEO of Providence. “This clearance signifies another leap forward in our mission to improve clinical outcomes for high-risk patients and prevent surgical failures of the spine.”